Protagonist Therapeutics, Inc.
PTGX
$56.25
$0.040.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 570.47M | 574.36M | 418.91M | 468.72M | 564.00M |
| Total Receivables | 27.97M | 27.09M | 168.49M | 2.67M | 1.37M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.09M | 4.41M | 4.24M | 5.38M | 5.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 602.53M | 605.86M | 591.64M | 476.77M | 570.93M |
|
|
|||||
| Total Current Assets | 602.53M | 605.86M | 591.64M | 476.77M | 570.93M |
| Net Property, Plant & Equipment | 12.70M | 12.53M | 12.61M | 12.30M | 12.03M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 290.00K | 225.00K | 225.00K | 225.00K | 225.00K |
| Total Assets | 718.01M | 742.13M | 744.73M | 603.86M | 614.63M |
|
|
|||||
| Total Accounts Payable | 3.25M | 2.92M | 1.62M | 3.05M | 3.63M |
| Total Accrued Expenses | 15.24M | 11.66M | 23.62M | 20.62M | 15.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.17M | 1.57M | 510.00K | 45.00K | -- |
| Total Finance Division Other Current Liabilities | 14.85M | 18.97M | 21.65M | 20.86M | 22.89M |
| Total Other Current Liabilities | 14.85M | 18.97M | 21.65M | 20.86M | 22.89M |
| Total Current Liabilities | 35.51M | 35.11M | 47.40M | 44.58M | 41.58M |
|
|
|||||
| Total Current Liabilities | 35.51M | 35.11M | 47.40M | 44.58M | 41.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.11M | 9.79M | 10.36M | 10.86M | 10.97M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.38M | 8.18M | 11.68M | 16.51M | 20.76M |
| Total Liabilities | 49.99M | 53.08M | 69.43M | 71.94M | 73.31M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.04B | 1.02B | 1.00B | 980.56M |
| Retained Earnings | -386.95M | -352.18M | -340.52M | -472.20M | -438.99M |
| Treasury Stock & Other | -15.00K | 85.00K | -82.00K | 1.34M | -249.00K |
| Total Common Equity | 668.02M | 689.05M | 675.30M | 531.92M | 541.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 668.02M | 689.05M | 675.30M | 531.92M | 541.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 668.02M | 689.05M | 675.30M | 531.92M | 541.32M |
|
|
|||||